CAR-T細胞療法市場：以標靶抗原、依治療應用、依地區分類

CAR T Cell Therapy Market, By Targeted Antigen, By Therapeutic Application, and By Region

出版日期: 2025年07月30日 | 出版商:

Coherent Market Insights | 英文 222 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

CAR-T細胞療法市場規模預計在2025年為39.9億美元，預計到2032年將達到150.6億美元，2025年至2032年的複合年成長率為20.9%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	39.9億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年	20.90%	2032年預測	150.6億美元

嵌合體抗原受體 (CAR) T 細胞療法是一種利用免疫 T 細胞來摧毀癌症的免疫療法。 CAR T 細胞療法也被稱為基於細胞的基因療法，因為它涉及 T 細胞的基因改造。在嵌合體抗原受體 (CAR) T 細胞療法中，T 細胞透過一種稱為白血球溶解的程序從人體中提取。然後，透過連接特定的嵌合體抗原受體 (CAR) 基因對其進行修飾，因此被稱為 CAR T 細胞。修飾後的細胞會持續生長，然後被輸注到人體。不同類型的 CAR T 細胞療法針對特定類型的癌症進行客製化。 CAR T 細胞會根據每位患者的情況進行客製化，並被輸注到血液中。 CAR T 細胞療法是一種新型的抗癌基因療法。目前正在進行各種臨床和臨床前測試，以研究各種 CAR T舉措療法針對特定癌症的安全性和有效性。此外，一些政府宣傳活動美國疾病管制與預防中心 (CDC)宣傳活動的教育活動，正在進行中，以提高大眾對癌症的認知。

市場動態

預計在預測期內，市場主要企業擴大採用產品核可等有機策略，將推動市場成長。例如，2022年5月，全球醫療保健公司諾華公司（Novartis AG）的Kymriah（tisagenlecleucel）CAR-T細胞療法獲得美國食品藥物管理局（FDA）核准，用於治療復發或難治性濾泡性淋巴瘤成年患者。核准基於一項II期臨床試驗，其中68%的患者反應良好。

本次調查的主要特點

本報告對全球 CAR T 細胞療法市場進行了詳細分析，展示了 2025 年至 2032 年期間的市場規模（十億美元）和年複合成長率（CAGR%），以 2024 年為基準年。
它還強調了各個領域的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數概述了全球 CAR T 細胞療法市場的主要企業。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、規模擴大、市場擴張和行銷策略做出明智的決策。
全球 CAR T 細胞療法市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過全球 CAR T 細胞療法市場分析中使用的各種策略矩陣更輕鬆地做出決策。

介紹
北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 東南亞國協
- 澳洲
- 韓國
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
非洲
- 北非
- 中部非洲
- 南非

第7章競爭態勢

Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
Novartis AG
CARsgenTherapeutics Co.,Ltd.
Aurora Biopharma
Legend BIoTech
Gilead Sciences, Inc.
Pfizer Inc.
bluebird bio, Inc.
Sorrento Therapeutics, Inc.
Mustang Bio
Fate Therapeutics

第 8 章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI102

Car T Cell Therapy Market is estimated to be valued at USD 3.99 Bn in 2025 and is expected to reach USD 15.06 Bn by 2032, growing at a compound annual growth rate (CAGR) of 20.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.99 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	20.90%	2032 Value Projection:	USD 15.06 Bn

Chimeric antigen receptor (CAR)-T cell therapy is a type of immunotherapy which uses immune T cells to destroy cancer. CAR T cell therapy is also called as cell based gene therapy, as it involves gene altering in T cells. For chimeric antigen receptor (CAR)-T cell therapy, T cells are extracted from human body using a procedure called leukapheresis. Then after extraction, T cells are altered by adding the gene for the specific chimeric antigen receptor (CAR) and hence they are called as CAR T cells. After the alteration, the cells are kept to grow and then are infused into human body. Different type of CAR T cell therapy are made to fight specific type of cancer. CAR- T cells are customized for different patients and then infused in blood. CAR T cells therapy is used as a novel gene therapy to fight cancer. Different clinical and preclinical studies are going on to study the safety and efficacy of various CAR-T cell therapies for specific cancer. Moreover, several governments are taking initiatives such as campaigns to spread the awareness of cancer for example educational campaign by Centers for Disease Control and Prevention (CDC).

Market Dynamics

Increasing adoption of organic strategies by key players in market such as product approval is expected to drive market growth over the forecast period. For instance, in May 2022, Novartis AG., one of the global healthcare company, received the U.S. Food and Drug Administration approval for Kymriah (tisagenlecleucel) CAR-T cell therapy for the treatment of adult patients with relapsed or refractory follicular lymphoma. The approval is based on phase II clinical trial, evaluated with 68% of positive response from the patients.

Key features of the study

This report provides in-depth analysis of the global CAR T cell therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global CAR T cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Novartis AG, CARsgenTherapeutics Co.,Ltd, Aurora Biopharma, Legend Biotech, Gilead Sciences, Inc., Pfizer Inc., bluebird bio, Inc., Sorrento Therapeutics, Inc., Mustang Bio, Fate Therapeutics among other prominent players.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global CAR T cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CAR T cell therapy market.

Market Segmentation

Global CAR T Cell Therapy Market, By Targeted Antigen
- CD19
- BCMA
- HER2
- GD2
- CD20
- CD22
- CD30
- CD33
- HER1
- Others (CLDN18, etc.)
Global CAR T Cell Therapy Market, By Therapeutic Application
- Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Diffuse Large B-cell Lymphoma (DLBCL)
- Follicular Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Glioblastoma
- Sarcoma
- Neuroblastoma
- Acute Myeloid Leukemia
- Breast Cancer
- Pancreatic Cancer
- Hepatocellular Carcinoma
- Colorectal Cancer
- Others (Gastric Cancer, etc.)
Global CAR T Cell Therapy Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
- Bristol-Myers Squibb Company
- Johnson & Johnson Services, Inc.
- Novartis AG
- CARsgenTherapeutics Co., Ltd.
- Aurora Biopharma
- Legend Biotech
- Gilead Sciences, Inc.
- Pfizer Inc.
- bluebird bio, Inc.
- Sorrento Therapeutics, Inc.
- Mustang Bio
- Fate Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Targeted Antigen
- Market Snapshot, By Therapeutic Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Regulatory Scenario
Pipeline Analysis
PEST Analysis
Porter's Analysis

4. Global CAR T Cell Therapy Market, By Targeted Antigen, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
CD19
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
BCMA
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
HER2
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
GD2
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
CD20
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
CD22
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
CD30
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
CD33
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
HER1
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (CLDN18, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global CAR T Cell Therapy Market, By Therapeutic Application, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Acute Lymphocytic Leukemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic Lymphocytic Leukemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diffuse Large B-cell Lymphoma (DLBCL)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Follicular Lymphoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Mantle Cell Lymphoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Multiple Myeloma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Glioblastoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sarcoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neuroblastoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Acute Myeloid Leukemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Breast Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pancreatic Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hepatocellular Carcinoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Gastric Cancer, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global CAR T Cell Therapy Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Targeted Antigen, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application , 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Targeted Antigen, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application , 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Targeted Antigen, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application , 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - UK
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Targeted Antigen, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application , 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Targeted Antigen, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application , 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Targeted Antigen, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application , 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CARsgenTherapeutics Co.,Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Aurora Biopharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Legend Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Gilead Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
bluebird bio, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sorrento Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mustang Bio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Fate Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies